EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estimating cost savings from reducing antibiotic overprescription in european general practices

Fabiana Raynal Floriano, Laura Vallejo-Torres, Marina Elistratova, Beatriz González López-Valcárcel, Ana García-Sangenís, Jesper Lykkegaard, Malene Plejdrup Hansen, Lars Bjerrum, Athina Chalkidou, Jette Nygaard Jensen, Ingrid Rebnord, Bent Håkan Lindberg und 19 weitere

The European Journal of Health Economics · 21.03.2026

DOI: 10.1007/s10198-026-01899-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Journal of Health Economics, online erschienen am 21.03.2026. Verfasst von Fabiana Raynal Floriano und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Quantitative Methods in Economics and Management, Universidad de Las Palmas de Gran Canaria, Juan de Quesada, 30, 35001, Las Palmas de …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de las Palmas de Gran Canaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antibiotic (ATB) overprescription leads to antimicrobial resistance (AMR) and adverse events (AEs) and poses significant economic burdens on European healthcare systems. The aim of this study was to assess the economic impact associated with interventions aimed at reducing unnecessary ATB prescriptions in general practice, and to extrapolate the results at the European Union (EU) level.

Methods

We used data from the “HAPPY PATIENT” project, a before-and-after study that implemented a multifaceted intervention in primary care settings in France, Greece, Lithuania, Poland, and Spain. Based on the outcomes observed in general practice across these five countries we extrapolated the results to estimate for each of the 27 EU member states: i) the costs of implementing the interventions, ii) the number of potentially unnecessary ATB prescriptions avoided, and iii) the potential savings due to reductions in unnecessary ATB prescriptions. We considered a realistic and an optimistic scenario: using the mean and the largest reduction in unnecessary ATB prescriptions observed across each of the five participating countries, respectively.

Results

Across the EU, €2.7 billion are estimated to be spent annually on healthcare resources linked to potentially unnecessary ATB prescribed in general practice. Implementing the interventions across the EU is projected to cost €107 million. Positive net savings were estimated in both scenarios, €151 million in the realistic scenario and €423 million in the optimistic scenario. Several sensitivity analyses were conducted to characterise the substantial uncertainty surrounding these estimates, which yielded considerable potential savings in all cases.

Schlagwörter

Stichwörter der Autor:innen

AntibioticsAntimicrobial resistanceCost savingsCostsOverusePrescriptions

Autor:innen und Institutionen

  • Department of Quantitative Methods in Economics and Management, Universidad de Las Palmas de Gran Canaria, Juan de Quesada, 30, 35001, Las Palmas de Gran Canaria, Canary Islands, Spain.
  • Department of Quantitative Methods in Economics and Management, Universidad de Las Palmas de Gran Canaria, Juan de Quesada, 30, 35001, Las Palmas de Gran Canaria, Canary Islands, Spain. laura.vallejo@ulpgc.es.
  • Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol, Gran Via de Les Corts Catalanes, 587 Àtic, 08007, Barcelona, Catalonia, Spain.
  • CIBER Enfermedades Infecciosas, Instituto de La Salud Carlos III, c. Sinesio Delgado 10, 28029, Madrid, Spain.
  • Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Campusvej 55, 5030, Odense, Funen, Denmark.
  • Research Unit for General Practice, Center for General Practice, Aalborg University, Fyrkildevej 79, 9220, Aalborg, Jutland, Denmark.

Förderung

  • Universidad de las Palmas de Gran Canaria

Zitieren

APA

Raynal Floriano, F., Vallejo-Torres, L., Elistratova, M., González López-Valcárcel, B., García-Sangenís, A., Lykkegaard, J., Hansen, M. P., Bjerrum, L., Chalkidou, A., Jensen, J. N., Rebnord, I., Lindberg, B. H., Taxis, K., Lambert, M., Radzeviciene, R., Jaruseviciene, L., Touboul-Lundgren, P., Bruno, P., Lesage, V., …, & Llor, C. (2026). Estimating cost savings from reducing antibiotic overprescription in european general practices. The European Journal of Health Economics. https://doi.org/10.1007/s10198-026-01899-3

Vancouver

Raynal Floriano F, Vallejo-Torres L, Elistratova M, González López-Valcárcel B, García-Sangenís A, Lykkegaard J, et al. Estimating cost savings from reducing antibiotic overprescription in european general practices. The European Journal of Health Economics. 2026. doi:10.1007/s10198-026-01899-3

BibTeX
@article{RaynalFloriano2026,
  author = {Raynal Floriano, Fabiana and Vallejo-Torres, Laura and Elistratova, Marina and González López-Valcárcel, Beatriz and García-Sangenís, Ana and Lykkegaard, Jesper and Hansen, Malene Plejdrup and Bjerrum, Lars and Chalkidou, Athina and Jensen, Jette Nygaard and Rebnord, Ingrid and Lindberg, Bent Håkan and Taxis, Katja and Lambert, Maarten and Radzeviciene, Ruta and Jaruseviciene, Lina and Touboul-Lundgren, Pia and Bruno, Pascale and Lesage, Vanessa and Kowalczyk, Anna and Godycki-Cwirko, Maciej and Lionis, Christos and Karkana, Maria -Nefeli and Anastasaki, Marilena and Hansen, Matilde Bøgelund and Olsen, Jonas Kanstrup and Søndergaard, Jens and Modena, Daniela and Mally, Stella and Álvarez, Laura and Llor, Carl},
  title = {Estimating cost savings from reducing antibiotic overprescription in european general practices},
  journal = {The European Journal of Health Economics},
  year = {2026},
  doi = {10.1007/s10198-026-01899-3}
}
Kostenlos starten →